Drug product
Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.
D-0924-2023
Product summary
- Event
- Event 92637
- Status
- Terminated
- Classification
- Class III
- Quantity
- 20,884 cartons
- Official record key
drug-enforcement:D-0924-2023
Official wording
Reason: Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.
Code information: Lot#: a) BAC0334A, Exp 06/2023; BAC0532A, Exp 11/2023 BAD0407A, Exp 08/2024 BAD0425A, Exp 08/2024; b) BAC0335A, Exp 06/2023, BAC0533A, Exp 10/2023, BAD0148A, Exp 03/2024, BAD0320A, Exp 07/2024
Distribution pattern: USA nationwide.
Derived failure modes
-
Potency or specification failure
Superpotent